Healius (ASX:HLS) has completed its operating & strategic review culminating in the sale of its Lumus Imaging unit for AU$965 million, according to a Thursday Australian bourse filing.
The sale to Affinity Equity Partners is expected to complete on May 1 and its proceeds will be used to pay shareholders a special dividend of AU$0.41 per share.
After the Lumus sale, the company said it would save AU$15 million to AU$20 million in costs by cutting unallocated corporate costs and pathology expenses.
The company's shares were up 13% in recent Thursday trade.